Cargando…
CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor
P53 represses transcription by activating p21 expression and promoting formation of RB1-E2F1 and RBL1/RBL2-DREAM transcription repressor complexes. The DREAM complex is composed of DP1, RB-family proteins RBL1 or RBL2 (p107/p130), E2F4/5, and MuvB. We recently reported RBL2-DREAM contributes to impr...
Autores principales: | Duan, Lei, Tadi, Mehrdad Jafari, Maki, Carl G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533896/ https://www.ncbi.nlm.nih.gov/pubmed/37759078 http://dx.doi.org/10.1038/s41598-023-43218-3 |
Ejemplares similares
-
RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC
por: Duan, Lei, et al.
Publicado: (2022) -
Author Correction: RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC
por: Duan, Lei, et al.
Publicado: (2022) -
HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes
por: Barrett, Alison, et al.
Publicado: (2023) -
DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation
por: Uxa, Sigrid, et al.
Publicado: (2019) -
TMB in NSCLC: A Broken Dream?
por: Bravaccini, Sara, et al.
Publicado: (2021)